Search research articles
Contact Us
Filters
Showing results (171-180 of 183) with videos related to
Page
of 19
Sort By:
Journal of Molecular Medicine (Berlin, Germany)
|
June 5, 2017
Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells
Chun-Yu Liu, Kuen-Feng Chen, Tzu-I Chao, et al.
Journal for Immunotherapy of Cancer
|
April 3, 2020
<i>PRKDC</i>: new biomarker and drug target for checkpoint blockade immunotherapy
Kien Thiam Tan, Chun-Nan Yeh, Yu-Chan Chang, et al.
EJNMMI Research
|
May 24, 2019
A phase 0 study of the pharmacokinetics, biodistribution, and dosimetry of <sup>188</sup>Re-liposome in patients with metastatic tumors
Shyh-Jen Wang, Wen-Sheng Huang, Chi-Mu Chuang, et al.
Oncotarget
|
June 20, 2015
Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma
Ming-Huang Chen, Chueh-Chuan Yen, Chi-Tung Cheng, et al.
Oncotarget
|
May 7, 2014
Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma
Ming-Huang Chen, Kun-Chun Chiang, Chi-Tung Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 18, 2022
Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study
Nai-Jung Chiang, Kien Thiam Tan, Li-Yuan Bai, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
September 17, 2025
FGFR2 Fusions or Rearrangements in Young Intrahepatic and Perihilar Cholangiocarcinoma Patients: Key Genetic Insights From a Pan-Asian Study
Yuta Maruki, Yasushi Yatabe, Chiharu Mizoguchi, et al.
Cancers
|
January 11, 2022
Microsatellite Instability, Epstein-Barr Virus, and Programmed Cell Death Ligand 1 as Predictive Markers for Immunotherapy in Gastric Cancer
Hung-Yuan Yu, Chung-Pin Li, Yi-Hsiang Huang, et al.
Cancer
|
August 20, 2025
Clinical outcomes of gastroenteropancreatic neuroendocrine neoplasms in Taiwan: A multicenter registry study-TCOG T1214 study
Hui-Jen Tsai, Ming-Huang Chen, Hsiu-Po Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 1, 2025
Carbon ion therapy for pancreatic cancer with risk-adapted dose escalation: initial clinical experience
I-Chun Lai, Yu-Mei Kang, Yuan-Hung Wu, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 183) with videos related to
Sort By:
Page
of 19
Journal of Molecular Medicine (Berlin, Germany)
|
June 5, 2017
Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells
Chun-Yu Liu, Kuen-Feng Chen, Tzu-I Chao, et al.
Journal for Immunotherapy of Cancer
|
April 3, 2020
<i>PRKDC</i>: new biomarker and drug target for checkpoint blockade immunotherapy
Kien Thiam Tan, Chun-Nan Yeh, Yu-Chan Chang, et al.
EJNMMI Research
|
May 24, 2019
A phase 0 study of the pharmacokinetics, biodistribution, and dosimetry of <sup>188</sup>Re-liposome in patients with metastatic tumors
Shyh-Jen Wang, Wen-Sheng Huang, Chi-Mu Chuang, et al.
Oncotarget
|
June 20, 2015
Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma
Ming-Huang Chen, Chueh-Chuan Yen, Chi-Tung Cheng, et al.
Oncotarget
|
May 7, 2014
Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma
Ming-Huang Chen, Kun-Chun Chiang, Chi-Tung Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 18, 2022
Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study
Nai-Jung Chiang, Kien Thiam Tan, Li-Yuan Bai, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
September 17, 2025
FGFR2 Fusions or Rearrangements in Young Intrahepatic and Perihilar Cholangiocarcinoma Patients: Key Genetic Insights From a Pan-Asian Study
Yuta Maruki, Yasushi Yatabe, Chiharu Mizoguchi, et al.
Cancers
|
January 11, 2022
Microsatellite Instability, Epstein-Barr Virus, and Programmed Cell Death Ligand 1 as Predictive Markers for Immunotherapy in Gastric Cancer
Hung-Yuan Yu, Chung-Pin Li, Yi-Hsiang Huang, et al.
Cancer
|
August 20, 2025
Clinical outcomes of gastroenteropancreatic neuroendocrine neoplasms in Taiwan: A multicenter registry study-TCOG T1214 study
Hui-Jen Tsai, Ming-Huang Chen, Hsiu-Po Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 1, 2025
Carbon ion therapy for pancreatic cancer with risk-adapted dose escalation: initial clinical experience
I-Chun Lai, Yu-Mei Kang, Yuan-Hung Wu, et al.
Page
of 19